Issue 3/2010
Content (21 Articles)
Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models
L. Vico, J-M. Vanacker
Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006
B. Abrahamsen, P. Vestergaard
FRAX® assessment of osteoporotic fracture probability in Switzerland
K. Lippuner, H. Johansson, J. A. Kanis, R. Rizzoli
Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial
N. Yuksel, S. R. Majumdar, C. Biggs, R. T. Tsuyuki
Fragility fractures of the hip and femur: incidence and patient characteristics
J. W. Nieves, J. P. Bilezikian, J. M. Lane, T. A. Einhorn, Y. Wang, M. Steinbuch, F. Cosman
Male risk factors for hip fracture—a 30-year follow-up study in 7,495 men
P. Trimpou, K. Landin-Wilhelmsen, A. Odén, A. Rosengren, L. Wilhelmsen
Does inadequate diet during childhood explain the higher high fracture rates in the Southern United States?
L. J. Paulozzi
The relationship between low bone mass and metabolic syndrome in Korean women
D.-K. Hwang, H.-J. Choi
Relationship between the mandibular inferior cortex and bone stiffness in elderly Japanese people
B. Kiswanjaya, A. Yoshihara, T. Deguchi, N. Hanada, H. Miyazaki
Laboratory reproducibility of biochemical markers of bone turnover in clinical practice
A. L. Schafer, E. Vittinghoff, R. Ramachandran, N. Mahmoudi, D. C. Bauer
Physical activity is the strongest predictor of calcaneal peak bone mass in young Swedish men
U. Pettersson, M. Nilsson, V. Sundh, D. Mellström, M. Lorentzon
Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS)
R. Barr, H. Macdonald, A. Stewart, F. McGuigan, A. Rogers, R. Eastell, D. Felsenberg, C. Glüer, C. Roux, D. M. Reid
The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort
P. F. Giampietro, C. McCarty, B. Mukesh, F. McKiernan, D. Wilson, A. Shuldiner, J. Liu, J. LeVasseur, L. Ivacic, T. Kitchner, N. Ghebranious
Height loss in elderly women is preceded by osteoporosis and is associated with digestive problems and urinary incontinence
J. Berecki-Gisolf, M. Spallek, R. Hockey, A. Dobson
Vertebral fracture assessment: impact of instrument and reader
B. Buehring, D. Krueger, M. Checovich, D. Gemar, N. Vallarta-Ast, H. K. Genant, N. Binkley
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
F. Borgström, O. Ström, J. Coelho, H. Johansson, A. Oden, E. V. McCloskey, J. A. Kanis
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease
M. H. Kriel, J. H. Tobias, T. J. Creed, M. Lockett, J. Linehan, A. Bell, R. Przemioslo, J. E. Smithson, T. N. Brooklyn, W. D. Fraser, C. S. J. Probert
High-resolution peripheral QCT imaging of bone micro-structure in adolescents
M. Burrows, D. Liu, H. McKay
High bone turnover in Irish professional jockeys
F. Waldron-Lynch, B. F. Murray, J. J. Brady, M. J. McKenna, A. McGoldrick, G. Warrington, G. O’Loughlin, J. M. Barragry
Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases
W. Park, N.-K. Kim, M.-Y. Kim, Y.-M. Rhee, H. J. Kim
Osteonecrosis of the jaw in patients receiving oral bisphosphonates
Athanassios Kyrgidis, Konstantinos Vahtsevanos